ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ALK Digital Pathology Outcome Predition, Multi Institutional, Restrospective Study	ALK-inhibitor Treated; Alk-positive Non-Small Cell Lung Cancer	Enrolling by invitation	Not stated	2025-02-26		NCT06846736

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Gustave Roussy, Cancer Campus, Grand Paris	93
Mayo Clinic	970
Sheba Medical Center	63

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Sheba Medical Center	Ramat Gan	Israel	11

Clinical trials